Found 3 publications.
Displayed publications from 1 to 3
Expand all publications
Collapse all publications
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. (Article ID: 496)
Trent MS
Biosynthesis, transport, and modification of lipid A
Biochemistry and Cell Biology 82(1) (2004)
71-86
Lipopolysaccharide (LPS) is the major surface molecule of Gram-negative bacteria and consists of three distinct structural domains: O-antigen, core, and lipid A. The lipid A (endotoxin) domain of LPS is a unique, glucosamine-based phospholipid that serves as the hydrophobic anchor of LPS and is the bioactive component of the molecule that is associated with Gram-negative septic shock. The structural genes encoding the enzymes required for the biosynthesis of Escherchia coli lipid A have been identified and characterized. Lipid A is often viewed as a constitutively synthesized structural molecule. However, determination of the exact chemical structures of lipid A from diverse Gram-negative bacteria shows that the molecule can be further modified in response to environmental stimuli. These modifications have been implicated in virulence of pathogenic Gram-negative bacteria and represent one of the molecular mechanisms of microbial surface remodeling used by bacteria to help evade the innate immune response. The intent of this review is to discuss the enzymatic machinery involved in the biosynthesis of lipid A, transport of the molecule, and finally, those enzymes involved in the modification of its structure in response to environmental stimuli.
lipopolysaccharides, lipide A, endotoxine, membrane externe, MsbA
NCBI PubMed ID: 15052329Journal NLM ID: 8606068Publisher: Ottawa: National Research Council of Canada
Correspondence: trentms

mailetsu.edu
Institutions: Department of Microbiology, Box 70579, East Tennessee State University, J.H. Quillen College of Medicine, Johnson City, TN 37614, U.S.A.
The publication contains the following compound(s):
- Compound ID: 1603
|
Lau-(1-3)-3HOMyr-(1-2)-+
|
3HOLau-(1-3)-+ |
| |
Lau-(1-3)-3HOMyr-(1-2)-+ | |
| | |
EtN-(1-0)-?%P---P--4)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1--P--0)--?%P-1)-EtN
| |
Kdop-(2-?)-Kdop-(2-6)-+ 3HOLau-(1-3)-+ |
Show graphically |
Structure type: oligomer
Compound class: lipid A
- Compound ID: 1602
|
?%Pam-(1-3)-R-3HOMyr-(1-2)-+
|
?%b-L-Arap4N-(1--P--4)--+ |
| |
Lau-(1-3)-R-3HOMyr-(1-2)-+ | |
| | |
a-Kdop-(2-4)-a-Kdop-(2-6)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1--P--0)--?%P-1)-EtN
| |
Myr-(1-3)-R-3HOMyr-(1-3)-+ |
|
R-3HOMyr-(1-3)-+ |
Show graphically |
Structure type: oligomer
Compound class: lipid A
- Compound ID: 1598
|
R-3HOMyr-(1-2)-+
|
R-3HOMyr-(1-3)-+ |
| |
R-3HOMyr-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
P-4)-+ |
|
R-3HOMyr-(1-3)-+ |
Show graphically |
Structure type: oligomer
Trivial name: lipid IV A, lipid IV(A)
Compound class: lipid A, glycolipid
- Compound ID: 1599
|
R-3HOMyr-(1-2)-+
|
P-4)-+ |
| |
R-3HOMyr-(1-2)-+ | |
| | |
a-Kdop-(2-4)-a-Kdop-(2-6)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
R-3HOMyr-(1-3)-+ |
|
R-3HOMyr-(1-3)-+ |
Show graphically |
Structure type: oligomer
Trivial name: Kdo2-lipid IVA
Compound class: LOS, lipid A
- Compound ID: 1600
|
R-3HOMyr-(1-2)-+
|
P-4)-+ |
| |
Lau-(1-3)-R-3HOMyr-(1-2)-+ | |
| | |
a-Kdop-(2-4)-a-Kdop-(2-6)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
Myr-(1-3)-R-3HOMyr-(1-3)-+ |
|
R-3HOMyr-(1-3)-+ |
Show graphically |
Structure type: oligomer
Trivial name: inner core, Kdo2-lipid A
Compound class: core oligosaccharide, LOS, lipid A
- Compound ID: 1601
|
?%Pam-(1-3)-R-3HOMyr-(1-2)-+
|
?%b-L-Arap4N-(1--P--4)--+ |
| |
a-Kdop-(2-4)-a-Kdop-(2-6)-+ | |
| | |
/Variants 0/-R-3HOMyr-(1-3)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1--P--0)--?%P-1)-EtN
| |
Lau-(1-3)-R-3HOMyr-(1-2)-+ |
|
?%R-3HOMyr-(1-3)-+
/Variants 0/ is:
Myr-(1-3)-
OR (exclusively)
2HOMyr-(1-3)- |
Show graphically |
Structure type: oligomer
Compound class: lipid A
- Compound ID: 1604
|
Kdop-(2-6)-+ 3HOSte-(1-2)-+
| |
Ste-(1-3)-3HOSte-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-0)-?%P-1)-EtN
|
3HOPam-(1-3)-+ |
Show graphically |
Structure type: oligomer
Compound class: lipid A
- Compound ID: 1605
|
?%3HODco-(1-3)-+
|
/Variants 0/-3HOLau-(1-2)-+ |
| |
Kdop-(2-?)-Kdop-(2-6)-+ | |
| | |
Lau-(1-3)-3HOLau-(1-2)-+ | | |
| | | |
?%b-L-Arap4N-(1--P--4)--b-D-GlcpN-(1-6)-a-D-GlcpN
| |
Pam-(1-3)-3HODco-(1-3)-+ |
|
?%b-L-Arap4N-(1--P--1)--+
/Variants 0/ is:
Lau-(1-3)-
OR (exclusively)
2HOLau-(1-3)- |
Show graphically |
Structure type: oligomer
Compound class: lipid A
Expand this publication
Collapse this publication
2. (Article ID: 565)
Kawasaki K, Ernst RK, Miller SI
3-O-Deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4
Journal of Biological Chemistry 279(19) (2004)
20044-20048
Toll-like receptor 4 (TLR4)-mediated responses, which are induced by the lipid A portion of lipopolysaccharide, are important for host defense against Salmonellae infection. A variety of different data indicate that the acylation state of lipid A can alter TLR4-mediated responses. The S. typhimurium virulence gene product PhoP/PhoQ signals the presence of host microenvironments to regulate the expression of a lipid A 3-O-deacylase, PagL, and a lipid A palmitoyltransferase, PagP. We now demonstrate that 3-O-deacylation and palmitoylation of lipid A decreases its ability to induce TLR4-mediated signaling. Deacylated lipid A, deacylated and palmitoylated lipid A, palmitoylated lipid A, and unmodified lipid A species were purified from Escherichia coli heterologously expressing PagL and/or PagP. The purified lipid A preparations showed spectra of a single lipid A species on mass spectrometry and gave a single band on thin layer chromatography. The activity of purified lipid A species was examined using human and mouse cell lines that express recombinant human TLR4. Compared with unmodified lipid A, the modified lipid A species are 30-100-fold less active in the ability to induce NF-kappaB-dependent reporter activation. These results suggest that the lipid A modifications reduce TLR4-signaling as part of Salmonellae adaptation to host environments.
Lipopolysaccharide, Escherichia coli, lipid A, mass spectrometrySalmonella typhimurium
NCBI PubMed ID: 15014080Publication DOI: 10.1074/jbc.M401275200Journal NLM ID: 2985121RPublisher: Baltimore, MD: American Society for Biochemistry and Molecular Biology
Correspondence: millersi

u.washington.edu
Institutions: Department of Microbiology, University of Washington, Seattle, WA 98195, USA
Methods: TLC, MALDI-TOF MS, biological assays, genetic methods, biochemical methods
The publication contains the following compound(s):
- Compound ID: 314
|
R-3HOMyr-(1-2)-+
|
Myr-(1-3)-R-3HOMyr-(1-3)-+ |
| |
Lau-(1-3)-R-3HOMyr-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
P-4)-+ |
|
R-3HOMyr-(1-3)-+ |
Show graphically |
Structure type: oligomer
Compound class: LPS, lipid A, glycolipid, phosphoglycolipid
- Compound ID: 1795
|
Pam-(1-3)-R-3HOMyr-(1-2)-+
|
Myr-(1-3)-R-3HOMyr-(1-3)-+ |
| |
Lau-(1-3)-R-3HOMyr-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
| |
P-4)-+ |
|
R-3HOMyr-(1-3)-+ |
Show graphically |
Structure type: oligomer
Compound class: lipid A
- Compound ID: 1796
|
Pam-(1-3)-R-3HOMyr-(1-2)-+
|
Myr-(1-3)-R-3HOMyr-(1-3)-+ |
| |
Lau-(1-3)-R-3HOMyr-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
|
P-4)-+ |
Show graphically |
Structure type: oligomer
Compound class: lipid A
- Compound ID: 1797
|
R-3HOMyr-(1-2)-+
|
Myr-(1-3)-R-3HOMyr-(1-3)-+ |
| |
Lau-(1-3)-R-3HOMyr-(1-2)-b-D-GlcpN-(1-6)-a-D-GlcpN-(1-P
|
P-4)-+ |
Show graphically |
Structure type: oligomer
Compound class: lipid A
Expand this publication
Collapse this publication
3. (Article ID: 8640)
Ma XK, Guo DD, Peterson EC, Dun Y, Li DY
Structural characterization and anti-aging activity of a novel extracellular polysaccharide from fungus Phellinus sp. in mammalian system
Food and Function 7(8) (2016)
3468-3479
Little is known about the chemical structure of purified extracellular polysaccharides from Phellinus sp., a fungal species with known medicinal properties. A combination of IR spectroscopy, methylation analysis and NMR were performed for the structural analysis of a purified extracellular polysaccharide derived from Phellinus sp. culture, denoted as SHP-1, along with an evaluation of the anti-aging effect in vivo of the polysaccharide supplementation. The structure of SHP-1 was established, with a backbone composed of →2,4)-α-D-glucopyranose-(1→ and →2)-β-D-mannopyranose-(1→ and two terminal glucopyranose branches. Biochemical analysis from mammalian animal experiments demonstrated that SHP-1 possesses the ability to enhance antioxidant enzyme activities, such as catalase (CAT) and superoxide dismutase (SOD) activities, Trolox equivalent antioxidant capacity (TEAC) in serum of D-galactose-aged mice, while reducing lipofuscin levels, another indicator of cell aging, indicating a potential association with anti-aging activities in a dose dependent manner. This compound had a favourable influence on immune organ indices, and a marked amelioration ability of histopathological hepatic lesions such as necrosis, karyolysis and reduced inflammation and apoptosis in mouse hepatocytes. These results suggest that SHP-1 has strong antioxidant activities and a significant protective effect against oxidative stress or hepatotoxicity induced by D-galactose in mice and it could be developed as a food ingredient or a pharmaceutical to prevent many age-associated diseases such as major depressive disorder and hepatotoxicity. To our knowledge, this is the first report on the antioxidant effects of a novel purified exopolysaccharide derived from Phellinus sp.
polysaccharide, extracellular, Antioxidant activity
NCBI PubMed ID: 27405813Publication DOI: 10.1039/C6fO00422AJournal NLM ID: 101549033Publisher: Cambridge: Royal Society of Chemistry
Correspondence: Ma XK
gmail.com>
Institutions: Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Science, Shaanxi Normal University, Xi'an, China, Department of Biochemical Engineering, Universidad Icesi, Cali, Colombia
Methods: 13C NMR, 1H NMR, IR, GC-MS, GC, FTIR, biochemical methods, HPLC, acetylation, ROESY, TOCSY, methylation analysis, HMBC, radical scavenging assay, DEPT, COSY, HSQC, TFA hydrolysis
The publication contains the following compound(s):
Expand this publication
Collapse this publication
Total list of publication IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: 4 sec